Alnylam Pharmaceuticals (ALNY) Q4 2024 Earnings

Oct 31Confirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-1.26
-0.88
-0.51
-0.13

Details

Expected EPS
-0.916627
Actual EPS
-0.87
Surprise EPS
0.05
Surprise Percent
+5.09%

Description

⁨Alnylam Pharmaceuticals⁩ (⁦ALNY⁩) has reported earnings of ⁦-0.87⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts